{
  "ptid_time": "099_S_2042_2012-08-21",
  "img_path": "/data/qiuhui/data/adni/images/099_S_2042/2012-08-21/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 71,456 mm³, 85.5% above the reference mean. With a Z-score of 2.05 (98.0th percentile), this represents significant enlargement; hippocampal volume measures 4,668 mm³, 38.2% below the reference mean. With a Z-score of -3.73 (0.0th percentile), this represents profound atrophy; whole brain volume measures 1,026,150 mm³, 4.9% below the reference mean. With a Z-score of -0.64 (26.1th percentile), this represents normal volume ; entorhinal cortex volume measures 2,328 mm³, 43.2% below the reference mean. With a Z-score of -2.93 (0.2th percentile), this represents significant atrophy; fusiform gyrus volume measures 18,100 mm³, 3.9% below the reference mean. With a Z-score of -0.33 (36.9th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,738 mm³, 7.5% below the reference mean. With a Z-score of -0.67 (25.0th percentile), this represents normal volume . ",
  "text_data": "Age is 71.5 years. Gender is Male. Education: 20 years. MMSE: 24.0. MoCA: 21.0. Logical Memory: 1.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.03 SUVR (normal ); Amyloid beta: 884.50 pg/mL (normal ); Total tau: 131.80 pg/mL (mild reduced); Phosphorylated tau: 11.04 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound hippocampal and entorhinal cortex atrophy, both strongly associated with Alzheimer's pathology, alongside significant ventricular enlargement (indicative of brain atrophy). Despite normal Aβ and AV45 (amyloid PET), the structural changes and cognitive scores (MMSE 24, MoCA 21) suggest neurodegeneration. The absence of APOE4 and normal amyloid reduces typical AD likelihood but doesn't rule out other dementias (e.g., hippocampal sclerosis, primary age-related tauopathy).  \n\n**Diagnosis:** **Dementia** (likely non-AD subtype, e.g., limbic-predominant neurodegeneration)  \n**Confidence:** **Medium** (due to atypical biomarker profile but severe atrophy/cognitive decline).  \n\n*Note: If hippocampal sclerosis or tauopathy is suspected, additional pathology (e.g., TDP-43, PART) would need evaluation.*",
  "timestamp": "2025-07-26T11:01:44.443058"
}